These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21825187)

  • 1. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
    Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
    Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of laser-induced choroidal neovascularization in African green monkeys.
    Goody RJ; Hu W; Shafiee A; Struharik M; Bartels S; López FJ; Lawrence MS
    Exp Eye Res; 2011 Jun; 92(6):464-72. PubMed ID: 21414311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
    Krzystolik MG; Afshari MA; Adamis AP; Gaudreault J; Gragoudas ES; Michaud NA; Li W; Connolly E; O'Neill CA; Miller JW
    Arch Ophthalmol; 2002 Mar; 120(3):338-46. PubMed ID: 11879138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
    Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
    Tolentino MJ; Brucker AJ; Fosnot J; Ying GS; Wu IH; Malik G; Wan S; Reich SJ
    Retina; 2004 Feb; 24(1):132-8. PubMed ID: 15076954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.
    Song SJ; Chung H; Yu HG
    Ophthalmic Res; 2008; 40(1):35-40. PubMed ID: 18032914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
    Heier JS; Brown DM; Chong V; Korobelnik JF; Kaiser PK; Nguyen QD; Kirchhof B; Ho A; Ogura Y; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Soo Y; Anderesi M; Groetzbach G; Sommerauer B; Sandbrink R; Simader C; Schmidt-Erfurth U;
    Ophthalmology; 2012 Dec; 119(12):2537-48. PubMed ID: 23084240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration.
    Nguyen QD; Shah SM; Hafiz G; Quinlan E; Sung J; Chu K; Cedarbaum JM; Campochiaro PA;
    Ophthalmology; 2006 Sep; 113(9):1522.e1-1522.e14. PubMed ID: 16876249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
    Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model.
    Lin X; Wang Q; He M
    Exp Eye Res; 2019 Jul; 184():1-7. PubMed ID: 30928489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap.
    Cao J; Zhao L; Li Y; Liu Y; Xiao W; Song Y; Luo L; Huang D; Yancopoulos GD; Wiegand SJ; Wen R
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):6009-17. PubMed ID: 20538989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Endothelial Growth Factor Receptor 2 Antibody, BC001, Attenuates Laser-Induced Choroidal Neovascularization in Rhesus Monkeys (Macaca mulatta).
    Zhao T; Zhang J; Zhang Y; Huang J; Wang X; Zhang Y; Zhang M; Yuan Y; Xiao K; Li H; Zhong Z
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):611-6. PubMed ID: 26334588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
    Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice.
    Mizutani T; Fowler BJ; Kim Y; Yasuma R; Krueger LA; Gelfand BD; Ambati J
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7122-9. PubMed ID: 26529046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
    Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.
    Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H
    Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.
    Lichtlen P; Lam TT; Nork TM; Streit T; Urech DM
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4738-45. PubMed ID: 20393113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing.
    Heier JS; Boyer D; Nguyen QD; Marcus D; Roth DB; Yancopoulos G; Stahl N; Ingerman A; Vitti R; Berliner AJ; Yang K; Brown DM;
    Ophthalmology; 2011 Jun; 118(6):1098-106. PubMed ID: 21640258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.